Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
Formulations: - Oral > Solid > tablet: 25 mg + 67.5 mg; 50 mg + 135 mg; 100 mg + 270 mg Oral > Solid > tablet: 25 mg + 67.5 mg; 50 mg + 135 mg; 100 mg + 270 mg tablet Indications: - Malaria due to Plasmodium falciparum - Malaria due to Plasmodium vivax Source: EML workbook import
Formulations: - Oral > Solid > tablet: 25 mg + 50 mg (as hydrochloride); 100 mg + 200 mg (as hydrochloride) Indications: - Malaria due to Plasmodium falciparum - Malaria due to Plasmodium vivax Source: EML workbook import
Formulations: - Oral > Solid > tablet: 60 mg + 180 mg (tetraphosphate) Oral > Solid > granules: 20 mg + 60 mg (tetraphosphate) Indications: - Malaria due to Plasmodium falciparum - Malaria due to Plasmodium vivax Source: EML workbook import
Formulations: - Oral > Solid > tablet: 50 mg [3] + 500 mg + 25 mg [1] in copackage (scored) Indications: - Malaria due to Plasmodium falciparum - Malaria due to Plasmodium vivax Source: EML workbook import
Formulations: - Oral > Solid > dispersible tablet: 20 mg + 160 mg (phosphate); 40 mg + 320 mg (phosphate) Oral > Solid > tablet: 40 mg + 320 mg (phosphate); 20 mg + 160 mg (phosphate); 60 mg + 480 (phosphate); 80 mg + 640 mg (phosphate) Indications: - Malaria due to Plasmodium falciparum - Malaria due to Plasmodium vivax Source: EML workbook import
Formulations: - Oral > Solid > tablet: 7.5 mg (as phosphate); 15 mg (as phosphate) Indications: - Malaria due to Plasmodium ovale - Malaria due to Plasmodium falciparum - Malaria due to Plasmodium vivax Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 300 mg per mL in 2 mL ampoule (hydrochloride) solution for infusion; 60 mg per mL in 2 mL ampoule (hydrochloride) solution for infusion Indications: - Malaria due to Plasmodium falciparum Source: EML workbook import
Formulations: - Oral > Solid: 300 to 500 mg - Local > Rectal > Suppository: 150 mg; 300 mg Oral > Solid > dispersible tablet: 75 mg; 300 mg; 500 mg Oral > Solid > tablet: 75 to 500 mg - Oral > Solid: 100 to 500 mg Local > Rectal > Suppository: 50 to 150 mg Indications: - Migraine - Acute rheumatic fever without mention of heart involvement - Mucocutaneous lymph node syndrome - Juvenile idiopathic arthritis - Pain Source: EML workbook import
Formulations: - Oral > Solid: 75 mg; 300 mg Indications: - Acute ischaemic heart disease - Presence of coronary angioplasty implant or graft Source: EML workbook import
Formulations: - Oral > Solid: 25 mg Indications: - Toxoplasmosis Source: EML workbook import
Formulations: - Oral > Solid: 50 mg tablet; 10 mg tablet (dispersible, scored) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Oral > Liquid: 100 mg granules for oral suspension Oral > Solid: 400 mg tablet; 25 mg tablet (chewable) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.
